NewsMedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 TrialMedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed...
News15O-water demonstrations at EANM’23: Experience the daily preparation and setup of MedTrace’s 15O-water automated manufacturing system15O-water demonstrations at EANM’23: Experience the daily preparation and setup of MedTrace’s 15O-water automated manufacturing system When The Annual European Association of Nuclear Medicine Congress...
ClinicalNewsMedTrace hosts 15O-water symposium for nuclear medicine professionalsMedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September...
NewsMedTrace expands patent portfolio and protects its 15O-water technologyMedTrace expands patent portfolio and protects its 15O-water technology The new patent protects how the company’s automated manufacturing system, P3 MT-100, produces and doses the...
NewsMedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual MeetingMedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting MedTrace Pharma is proud to participate with a clinical booth and share the...
ClinicalNewsMedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical DevicesMedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices MedTrace is now ISO 13485 certified for the company’s quality management system in medical...
ClinicalNewsFirst U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 TrialFirst U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 Trial The first U.S. patient in MedTrace’s phase 3 clinical trial has been dosed and scanned...
ClinicalNewsNew findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgeryNew findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery 15O-water PET MPI may be a...
ClinicalNewsAarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imagingAarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging From tumors and lung cancer to rib fractures and COVID-19 infiltrates. Researchers...
ClinicalNewsFirst Oncology Patient Scanned with 15O-water on MedTrace EquipmentFirst Oncology Patient Scanned with 15O-water on MedTrace Equipment MedTrace’s automated manufacturing system at the installation at The Department of Nuclear Medicine and Tracer Kinetics...
ClinicalNewsMedTrace receives U.S. patent for diagnosing the human heartMedTrace receives U.S. patent for diagnosing the human heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the...
NewsCEO stepping down; MedTrace will intensify its efforts to complete the phase 3 clinical trialCEO stepping down MedTrace will intensify its efforts to complete the phase 3 clinical trial MedTrace will intensify efforts to complete its phase 3 clinical...
ClinicalNews15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans”...
ClinicalConferencesNewsMedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-waterMedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-water On October 17, 2022, MedTrace hosted a...
NewsPeopleMedTrace inaugurates U.S. headquarters in downtown MinneapolisMedTrace inaugurates U.S. headquarters in downtown Minneapolis Danish-born MedTrace is opening its new U.S. headquarters in Minneapolis’ IDS Center on September 7, 2022. The company...
ClinicalNewsMedTrace Announces First Subject Scanned in Phase 3 Clinical TrialMedTrace Pharma Announces First Subject Scanned in the Company’s RAPID-WATER-FLOW Phase 3 Clinical Trial First Subject Scanned in RAPID-WATER-FLOW Trial at Aarhus University Hospital, Denmark...
NewsPeopleMedTrace expands management with financial strategist as CFOMedTrace expands management and appoints financial strategist heavyweight as CFO Ann Kristin Led, former Exec. Vice President of Finance and Strategy at pharma company MC2...
ClinicalNewsMedTrace announces IND approval of RAPID-WATER phase 3 clinical trialMedTrace Pharma announces IND approval with the initiation of RAPID-WATER phase 3 clinical trial MedTrace Pharma A/S announced today the FDA approval of the company’s...
ClinicalNewsMedTrace Pharma takes step towards CE markingMedTrace Pharma takes step towards CE marking A notified body has signed a contract to review MedTrace Pharma’s aQuant software and patient kit products with...
ClinicalNewsMedTrace Installs P3 System at Sahlgrenska University HospitalMedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation...
